Agenus Inc [AGEN] stock is trading at $0.59, up 1.29%. An important factor to consider is whether the stock is rising or falling in short-term value. The AGEN shares have gain 7.58% over the last week, with a monthly amount drifted -12.31%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 14, March 2024, Agenus Reports Fourth Quarter and Full Year 2023 Results. In a post published today on Yahoo Finance, FDA Grants Fast Track designation for BOT/BAL in metastatic, refractory colorectal cancer (CRC) patients who have failed 1st and 2nd line standard of care treatments.
From an analyst’s perspective:
Agenus Inc [NASDAQ: AGEN] stock has seen the most recent analyst activity on June 06, 2023, when Robert W. Baird initiated its Outperform rating and assigned the stock a price target of $8. Previously, Robert W. Baird started tracking the stock with Outperform rating on June 06, 2023, and set its price target to $80. SMBC Nikko started tracking the stock assigning a Outperform rating and suggested a price target of $5 on September 28, 2022. H.C. Wainwright initiated its recommendation with a Buy and recommended $12 as its price target on December 16, 2021. In a note dated April 22, 2019, B. Riley FBR initiated an Buy rating.
Agenus Inc [AGEN] stock has fluctuated between $0.49 and $2.13 over the past year. Agenus Inc [NASDAQ: AGEN] shares were valued at $0.59 at the most recent close of the market.
Analyzing the AGEN fundamentals
Agenus Inc [NASDAQ:AGEN] reported sales of 156.31M for the trailing twelve months, which represents a growth of 195.22%. Gross Profit Margin for this corporation currently stands at -0.13% with Operating Profit Margin at -1.02%, Pretax Profit Margin comes in at -1.65%, and Net Profit Margin reading is -1.6%. To continue investigating profitability, this company’s Return on Assets is posted at -0.8, Equity is 2.26 and Total Capital is -2.75. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at -1.77.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.5684 points at the first support level, and at 0.5492 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.5991, and for the 2nd resistance point, it is at 0.6106.
Agenus Inc [AGEN] reported earnings per share of -$0.13 for its fiscal quarter that ended on 12/30/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$0.05/share, meaning a difference of -$0.08 and a surprise factor of -160.00%. By comparison, the stated earnings for the previous quarter ended on 9/29/2023 were -$0.16 per share as compared to estimates of -$0.19 per share, a difference of $0.03 representing a surprise of 15.80%.
Ratios To Look Out For
For context, Agenus Inc’s Current Ratio is 0.44. On the other hand, the Quick Ratio is 0.44, and the Cash Ratio is 0.3. Considering the valuation of this stock, the price to sales ratio is 1.57.
Transactions by insiders
Recent insider trading involved ARMEN GARO H,, that happened on Feb 15 ’24 when 0.5 million shares were purchased. Director, WIINBERG ULF completed a deal on Nov 15 ’23 to buy 25000.0 shares. Meanwhile, 10% Owner AGENUS INC bought 429.0 shares on Oct 16 ’23.
